首页> 外文期刊>Surgical Endoscopy >Percutaneous endoscopic gastrostomy/jejunostomy (PEG/PEJ) for decompression in the upper gastrointestinal tract. Initial experience with palliative treatment of gastrointestinal obstruction in terminally ill patients with advanced carcinomas.
【24h】

Percutaneous endoscopic gastrostomy/jejunostomy (PEG/PEJ) for decompression in the upper gastrointestinal tract. Initial experience with palliative treatment of gastrointestinal obstruction in terminally ill patients with advanced carcinomas.

机译:经皮内镜下胃造口术/空肠造口术(PEG / PEJ)用于上消化道减压。晚期癌症晚期患者的姑息治疗胃肠道阻塞的初步经验。

获取原文
获取原文并翻译 | 示例
       

摘要

BACKGROUND: Signs of gastrointestinal obstruction, with intractable vomiting and an inability to take oral food, are common symptoms in terminally ill cancer patients with advanced primary tumors or peritoneal carcinomatosis. The application of percutaneous endoscopic gastrostomy or jejunostomy (PEG/PEJ) instead of the usual nasoenteral tube is a simple method of achieving permanent decompression in the upper gastrointestinal tract. The goals of this study, in addition to establishing indications and outcome, were to identify specific aspects of tube placement and to determine the incidence of complications. METHOD: Over a period of 3 years, a total of 24 consecutive patients (mean age, 64 years; range, 37-83 years) underwent either a PEG (17/71%) or a PEJ (seven/29%). RESULTS: In all patients, PEG/PEJ obviated the need for the nasoenteral tube. A total of 22 patients (92%) were enabled to take liquids orally, and 20 (83%) were discharged to home care. With the exception of a single spontaneous dislodgement of the PEG tube, no major complications were observed. CONCLUSION: We believe that PEG/PEJ represents an effective, minimally invasive, and cost-effective method for gastrointestinal decompression in patients with advanced incurable cancer.
机译:背景:在患有晚期原发性肿瘤或腹膜癌的绝症癌症患者中,常见的症状是胃肠道阻塞,呕吐难忍和无法口服食物。经皮内镜下胃造口术或空肠造口术(PEG / PEJ)代替通常的鼻肠管是一种实现上消化道永久减压的简单方法。这项研究的目标,除了确定适应症和结局外,还旨在确定管放置的特定方面并确定并发症的发生率。方法:在3年的时间里,总共有24位连续患者(平均年龄64岁;范围37-83岁)接受PEG(17/71%)或PEJ(7/29%)。结果:在所有患者中,PEG / PEJ消除了对鼻肠管的需求。共有22例患者(92%)能够口服液体,其中20例(83%)出院了。除了PEG管自发性移位外,未观察到重大并发症。结论:我们认为PEG / PEJ是晚期顽固性癌症患者胃肠道减压的一种有效,微创且经济高效的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号